Velmanase alfa Completed Phase 3 Trials for Alpha-Mannosidosis Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01908712Lamazym Aftercare Study FR Designed to Provide Treatment for French Patients
NCT01908725Lamazym Aftercare Study
NCT02478840Evaluation of Long-term Efficacy of Treatment With Lamazym
NCT01681953A Placebo-Controlled Phase 3 Trial of Repeated Lamazym Treatment of Subjects With Alpha-Mannosidosis